NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Telemedicine Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Hopitaux Universitaires de Geneve, Geneva, Switzerland



Recent findings in transplants described by researchers from Switzerland, Spain and the United Kingdom



September 13th, 2006

Transplants research advances have been reported from Switzerland, Spain and the United Kingdom.

Study 1: Hepatopulmonary syndrome increases the postoperative mortality rate after liver transplantation.

Scientists writing in the American Journal of Transplantation report, "Hepatopulmonary syndrome (HPS) is a frequent pulmonary complication of patients with end-stage liver diseases. HPS is diagnosed by hypoxemia and pulmonary vascular dilatation and is an independent risk factor of mortality. Orthotopic liver transplantation (OLT) is the only factor that modifies the natural course of HPS. Once patients with HPS have been transplanted, their...


Source: Telemedicine Business Week (2006-09-13)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login